Shandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement

Bulletin Express03-31

Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing retirement due to age.

The company confirmed that Xu Lie has no disagreements with the Board and is unaware of any matters needing shareholder or Hong Kong Stock Exchange attention. Following his departure, Xu Lie no longer holds any position within the group.

Current board composition is as follows:

• Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning, Cheung Ching Ching, Daisy • Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue • Non-executive Director: Zhang Chengyong

The Board expressed appreciation for Xu Lie’s contributions during his tenure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment